Gastrinoma
The approach to treatment often depends on the results of preoperative localization studies and findings at exploratory laparotomy. At exploration, 85% of these tumors are found in the gastrinoma triangle with 40% on the surface of the pancreas and 40% outside of the pancreas. Only 15% are found within the substance of the pancreas. Percutaneous transhepatic venous sampling may occasionally provide accurate localization of single sporadic gastrinomas. Total gastrectomy is no longer considered the immediate treatment of choice and is selectively used depending on effectiveness of other treatment programs.[1]
Standard treatment options:
General Information About Childhood Acute Lymphoblastic Leukemia (ALL)
The National Cancer Institute provides the PDQ pediatric cancer treatment information summaries as a public service to increase the availability of evidence-based cancer information to health professionals, patients, and the public. Fortunately, cancer in children and adolescents is rare, although the overall incidence of childhood cancer has been slowly increasing since 1975.[1] Children and adolescents with cancer should be referred to medical centers that have a multidisciplinary team of cancer...
Read the General Information About Childhood Acute Lymphoblastic Leukemia (ALL) article > >
- Single lesion in head of the pancreas:
- Enucleation.
- Parietal cell vagotomy and cimetidine.
- Total gastrectomy (in very unusual circumstances).
- Single or multiple lesions in the duodenum:
- Pancreatoduodenectomy.
- Single lesion in body/tail of the pancreas:
- Resection of body/tail.
- Multiple lesions in pancreas:
- Resection of body/tail and, if residual disease is present,
- Parietal cell vagotomy and cimetidine, or
- Total gastrectomy.
- No tumor found:
- Parietal cell vagotomy and cimetidine.
- Total gastrectomy.
-
Liver metastases:
- Liver resection where possible; radiofrequency ablation and cryosurgical ablation are options.
- Chemoembolization of liver.
- Metastatic disease or disease refractory to surgery and cimetidine:
- Combination chemotherapy: doxorubicin plus streptozocin or fluorouracil plus streptozocin in patients when doxorubicin is contraindicated.[2]
- Somatostatin analogue therapy (SMS 201-995).[3]
Patients with hepatic-dominant disease and substantial symptoms caused by tumor bulk or hormone-release syndromes may benefit from procedures that reduce hepatic arterial blood flow to metastases (hepatic arterial occlusion with embolization or with chemoembolization). Such treatment may also be combined with systemic chemotherapy in selected patients.[4] Treatment with proton pump inhibitors or H2 blocking agents may aid in control of peptic symptoms.
Current Clinical Trials
Check for U.S. clinical trials from NCI's list of cancer clinical trials that are now accepting patients with gastrinoma. The list of clinical trials can be further narrowed by location, drug, intervention, and other criteria.
General information about clinical trials is also available from the NCI Web site.
References:
- Glowniak JV, Shapiro B, Vinik AI, et al.: Percutaneous transhepatic venous sampling of gastrin: value in sporadic and familial islet-cell tumors and G-cell hyperfunction. N Engl J Med 307 (5): 293-7, 1982.
- Moertel CG, Lefkopoulo M, Lipsitz S, et al.: Streptozocin-doxorubicin, streptozocin-fluorouracil or chlorozotocin in the treatment of advanced islet-cell carcinoma. N Engl J Med 326 (8): 519-23, 1992.
- Kvols LK, Buck M, Moertel CG, et al.: Treatment of metastatic islet cell carcinoma with a somatostatin analogue (SMS 201-995). Ann Intern Med 107 (2): 162-8, 1987.
- Moertel CG, Johnson CM, McKusick MA, et al.: The management of patients with advanced carcinoid tumors and islet cell carcinomas. Ann Intern Med 120 (4): 302-9, 1994.
WebMD Public Information from the National Cancer Institute
Today in Cancer
WebMD Special Sections
Health Solutions From Our Sponsors
©2005-2012 WebMD, LLC. All rights reserved.
WebMD does not provide medical advice, diagnosis or treatment. See additional information.